Back to Search
Start Over
LBA38 Bexmarilimab, a novel macrophage re-programmer shows promising anti-tumour activity in phase I/II trial in several last line solid tumour types
- Source :
- Annals of Oncology. 32:S1313
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
Details
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........16b4316c39955d961f1f03170ea40d4b
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.08.2115